https://www.marketscreener.com/quote/stock/INNOVENT-BIOLOGICS-INC-49476402/news/Innovent-Biologics-Inc-Announces-First-Participant-Dosed-in-Phase-1-Clinical-Study-of-IBI333-Vegf-43106692/?utm_source=telegram&utm_medium=social&utm_campaign=share